Skip to main content
. 2018 Jul 17;22(4):323–327. doi: 10.1016/j.bjid.2018.06.003

Table 3.

Clinical outcomes in viridans group streptococci (VGS) group bacteremia.

Anginosus (n = 14) Mitis (n = 20) Sanguinis (n = 7) Total (n = 43)
Septic shock 4 (28.6%) 2 (10%) 3 (42.9%) 9 (20.9%)
Mechanical ventilation 2 (14.3%) 1 (5%) 3 (42.9%) 6 (14.0%)
Intensive care unit 2 (14.3%) 0 (0.0%) 1 (14.3%) 3 (7.0%)
48 h mortality 2 (14.3%) 1 (5%) 2 (28.6%) 5 (11.6%)
30-day mortality 3 (21.4%) 2 (10%) 3 (42.9%) 8 (18.6%)